Cargando…

Intracellular FGF1 protects cells from apoptosis through direct interaction with p53

Fibroblast growth factor 1 (FGF1) acts by activating specific tyrosine kinase receptors on the cell surface. In addition to this classical mode of action, FGF1 also exhibits intracellular activity. Recently, we found that FGF1 translocated into the cell interior exhibits anti-apoptotic activity inde...

Descripción completa

Detalles Bibliográficos
Autores principales: Lampart, Agata, Krowarsch, Daniel, Biadun, Martyna, Sorensen, Vigdis, Szymczyk, Jakub, Sluzalska, Katarzyna, Wiedlocha, Antoni, Otlewski, Jacek, Zakrzewska, Malgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545594/
https://www.ncbi.nlm.nih.gov/pubmed/37783936
http://dx.doi.org/10.1007/s00018-023-04964-9
Descripción
Sumario:Fibroblast growth factor 1 (FGF1) acts by activating specific tyrosine kinase receptors on the cell surface. In addition to this classical mode of action, FGF1 also exhibits intracellular activity. Recently, we found that FGF1 translocated into the cell interior exhibits anti-apoptotic activity independent of receptor activation and downstream signaling. Here, we show that expression of FGF1 increases the survival of cells treated with various apoptosis inducers, but only when wild-type p53 is present. The p53-negative cells were not protected by either ectopically expressed or translocated FGF1. We also confirmed the requirement of p53 for the anti-apoptotic intracellular activity of FGF1 by silencing p53, resulting in loss of the protective effect of FGF1. In contrast, in p53-negative cells, intracellular FGF1 regained its anti-apoptotic properties after transfection with wild-type p53. We also found that FGF1 directly interacts with p53 in cells and that the binding region is located in the DBD domain of p53. We therefore postulate that intracellular FGF1 protects cells from apoptosis by directly interacting with p53. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-023-04964-9.